while everyone is focused on the Vaxinia trial update I am expecting if not more excited to see further evidence Her-vaxx is a commercially near term reality.
I believe the current share price capping is in preparation of a Her-vaxx sale or licensing deal. That’s our short term rerate
IMO
while everyone is focused on the Vaxinia trial update I am...
-
- There are more pages in this discussion • 3,309 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.0¢ |
Change
-0.001(1.96%) |
Mkt cap ! $367.4M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.2¢ | 5.0¢ | $627.5K | 12.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 69 | 6016291 | 5.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.1¢ | 460460 | 7 |
View Market Depth
| Last trade - 16.10pm 06/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |